Who We Are

Who We Are

Carie Boyd Pharmaceuticals specializes in compounding a diverse range of office-use and patient-specific medications. With a 503B outsourcing facility and 503A specialty compounding pharmacy, we are able to address nearly all the compounding needs of healthcare providers and their patients.

Founded in 1965 as a local community pharmacy, our journey began by collaborating with general practitioners, urologists, and OB-GYNs in the Dallas-Ft. Worth area. As our expertise in hormones began to draw more attention, we quickly expanded and started supplying medications to healthcare providers in neighboring states. By 2012, we had emerged as a leading supplier of implantable subcutaneous hormone pellets, which quickly made us a sought after compounding partner for providers from coast to coast.

In 2015, we became one of the first to register a facility with the FDA as a 503B outsourcing facility. Our outsourcing facility enabled us to fulfill bulk orders of compounded medications without any prescriptions, keep compounded medications in inventory so that we could quickly fulfill orders, and help healthcare providers and healthcare systems ensure that they have stable, consistent, and immediately-available supplies of important medications.

Today, Carie Boyd Pharmaceuticals is a recognized industry leader that is continuously seeking opportunities to support our customers and their patients. We are dedicated to supplying patients and the broader healthcare system with the highest-quality compounded medications, unparalleled service, and innovative solutions. Our goal is to provide our customers with unique medications quickly, easily, and consistently.

Carie Boyd Pharmaceuticals specializes in compounding a diverse range of office-use and patient-specific medications. With a 503B outsourcing facility and 503A specialty compounding pharmacy, we are able to address nearly all the compounding needs of healthcare providers and their patients.
Founded in 1965 as a local community pharmacy, our journey began by collaborating with general practitioners, urologists, and OB-GYNs in the Dallas-Ft. Worth area. As our expertise in hormones began to draw more attention, we quickly expanded and started supplying medications to healthcare providers in neighboring states. By 2012, we had emerged as a leading supplier of implantable subcutaneous hormone pellets, which quickly made us a sought after compounding partner for providers from coast to coast.
In 2015, we became one of the first to register a facility with the FDA as a 503B outsourcing facility. Our outsourcing facility enabled us to fulfill bulk orders of compounded medications without any prescriptions, keep compounded medications in inventory so that we could quickly fulfill orders, and help healthcare providers and healthcare systems ensure that they have stable, consistent, and immediately-available supplies of important medications.
Today, Carie Boyd Pharmaceuticals is a recognized industry leader that is continuously seeking opportunities to support our customers and their patients. We are dedicated to supplying patients and the broader healthcare system with the highest-quality compounded medications, unparalleled service, and innovative solutions. Our goal is to provide our customers with unique medications quickly, easily, and consistently.
Previous slide
Next slide

Quality

At our 503B outsourcing facility, we adhere to the Current Good Manufacturing Practices (cGMP) set forth in Title 21 of the Code of Federal Regulations parts 210 and 211.  These standards are the same as those to which large commercial pharmaceutical manufacturers are held.  They help ensure the identity, strength, quality, and purity of compounded medications while simultaneously helping to prevent contamination.  While cGMP standards are robust and challenging for any compounder to meet, we endeavor to exceed them.  

In addition, both our 503B outsourcing facility and 503A specialty compounding pharmacy comply with the United States Pharmacopeia (USP).  USP standards are recognized by the Feder Food, Drug, and Cosmetic Act, and in rules, laws, regulations, and policies promulgated by the states.

Service

Providing our customers with unparalleled, superior service is fundamental to who we are.

  • Same day order fulfillment
  • Timely delivery
  • Customer service department dedicated to fulfilling your needs
  • Knowledgeable and friendly staff
  • Pharmacists with clinical expertise available to help customize medications

Innovation

Our ongoing commitment to innovating new products and processes has made us a thought-leader in the healthcare industry.

  • Developed modern-day automated implantable subcutaneous hormone pellet manufacturing process
  • Research and development team charged with developing new products and processes
  • Collaboration with regulators on new developments
  • Science-based development process
  • Strategic partnerships with other industry innovator

Quality

At our 503B outsourcing facility, we adhere to the Current Good Manufacturing Practices (cGMP) set forth in Title 21 of the Code of Federal Regulations parts 210 and 211.  These standards are the same as those to which large commercial pharmaceutical manufacturers are held.  They help ensure the identity, strength, quality, and purity of compounded medications while simultaneously helping to prevent contamination.  While cGMP standards are robust and challenging for any compounder to meet, we endeavor to exceed them.  

In addition, both our 503B outsourcing facility and 503A specialty compounding pharmacy comply with the United States Pharmacopeia (USP).  USP standards are recognized by the Feder Food, Drug, and Cosmetic Act, and in rules, laws, regulations, and policies promulgated by the states.

Service

Providing our customers with unparalleled, superior service is fundamental to who we are.

  • Same day order fulfillment
  • Timely delivery
  • Customer service department dedicated to fulfilling your needs
  • Knowledgeable and friendly staff
  • Pharmacists with clinical expertise available to help customize medications

Innovation

Our ongoing commitment to innovating new products and processes has made us a thought-leader in the healthcare industry.

  • Developed modern-day automated implantable subcutaneous hormone pellet manufacturing process
  • Research and development team charged with developing new products and processes
  • Collaboration with regulators on new developments
  • Science-based development process
  • Strategic partnerships with other industry innovator
OUR

Products